Drugs administered during center-specific consolidation after induction
| Consolidation course . | Overall, N = 37 n (%) . |
|---|---|
| Intermediate-dose Ara-C (≤10 g/m2 total dose) | 27 (73) |
| High-dose Ara-C (>10 g/m2 total dose) | 8 (22) |
| Intermediate-dose anthracycline (≤8 mg/m2 of idarubicin or equivalent total dose) | 20 (54) |
| High-dose anthracycline (>8 mg/m2 of idarubicin or equivalent total dose) | 7 (19) |
| Fludarabine as third agent | 21 (57) |
| Amsacrine | 2 (5) |
| High-dose Ara-C and/or high-dose anthracycline | 13 (35) |
| Consolidation course . | Overall, N = 37 n (%) . |
|---|---|
| Intermediate-dose Ara-C (≤10 g/m2 total dose) | 27 (73) |
| High-dose Ara-C (>10 g/m2 total dose) | 8 (22) |
| Intermediate-dose anthracycline (≤8 mg/m2 of idarubicin or equivalent total dose) | 20 (54) |
| High-dose anthracycline (>8 mg/m2 of idarubicin or equivalent total dose) | 7 (19) |
| Fludarabine as third agent | 21 (57) |
| Amsacrine | 2 (5) |
| High-dose Ara-C and/or high-dose anthracycline | 13 (35) |